This trial is trying to determine the best way of delivering radiation therapy to the breast tissue of people diagnosed with invasive, Grade 1, 2 or 3 breast cancer, before surgery.
This trial is treating patients with breast cancer.
This is a radiotherapy trial.
You may be able to join this trial if:
- You have had a certain type of treatment or surgical procedure.
You may be excluded from this trial if:
- You have a certain disease or psychological condition.
- You have had certain treatments, surgical procedures or drugs.
Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.
Clinical Summary Read More
Use the hyperlinks, where available to access additional clinical trial information.
A Pilot Study of Prone Position Neoadjuvant Breast Radiotherapy to Reduce Skin Toxicity
Other Non-Commercial Sponsor
Victorian Comprehensive Cancer Centre & Peter MacCallum Cancer Centre
The duration of this trial is expected to be 3 months for each participant. Radiotherapy treatment will commence at least 4-weeks after completion of standard chemotherapy and will be delivered 5-days a week, over 5-weeks. Approximately 4-8 weeks following successful completion of radiotherapy, the participant will have a surgery to remove the breast and immediate breast reconstruction.
Recruiting Hospitals Read More